Axial3D

Axial3D develops AI-powered 3D medical imaging solutions that enable patient-specific surgical planning and medical device development. The platform empowers medical device companies and hospitals with precise, automated segmentation and planning solutions that streamline workflows, reducing manual effort and helping clinicians focus on achieving optimal outcomes for each patient. Axial3D transforms 2D medical images into detailed 3D anatomical models used for surgical planning, device customization, and personalized care across specialties including orthopedics and cardiovascular surgery. The company collaborates with Ulster University through a Knowledge Transfer Partnership programme and has been spotlighted by Reuters as part of Northern Ireland growing life sciences momentum. Axial3D positions itself as the digital foundation of personalized surgery, making patient-specific care routine through data-driven 3D solutions that integrate AI and advanced manufacturing for delivering personalized surgical tools, devices, and navigation systems. Founded in 2014 and headquartered in Belfast, United Kingdom, Axial3D has raised approximately $44.7 million in Series C funding from investors including Stratasys, Nvidia, Techstart Ventures, Invest Northern Ireland, Future Fund, British Business Bank, and 57 Stars.